Chemical Compound

FENRETINIDE

CAS Registry Number 65646-68-6
Back to search Request a Quote
FENRETINIDE chemical structure
Primary Record

FENRETINIDE

In stock
4,982 g
Purity
99.4 %
CAS
65646-68-6

Compound Identifiers & Properties

CAS
65646-68-6
PubChem CID
5288209
SMILES
CC1=C(C(CCC1)(C)C)/C=C/C(=C/C=C/C(=C/C(=O)NC2=CC=C(C=C2)O)/C)/C
Canonical SMILES
CC1=C(/C=C/C(C)=C/C=C/C(C)=C/C(=O)Nc2ccc(O)cc2)C(C)(C)CCC1

Names & Synonyms

  • FENRETINIDE
  • N-(4-Hydroxyphenyl)retinamide
  • 4-hydroxyphenylretinamide
  • 4-HPR
  • Fenretinida
  • 65646-68-6
  • Fenretinidum
  • Fenretinimide
  • 4-Hydroxyphenyl retinamide
  • Rii retinamide
  • Retinoic acid p-hydroxyanilide
  • all-trans-4'-Hydroxyretinanilide
  • Fenretinidum [Latin]
  • Fenretinida [Spanish]
  • McN-R-1967
  • 4-hydroxy(phenyl)retinamide
  • Fenretinide [USAN:INN]
  • RETINAMIDE
  • Retinamide, N-(4-hydroxyphenyl)-
  • Fenretinide; 4-HPR
  • 4 Hydroxyphenylretinamide
  • 4HPR
  • Fenretinide, 13 cis
  • 187EJ7QEXL
  • Methyl 4-fluorobenzoate
  • 13-cis-Isomer Fenretinide
  • p-Hydroxyphenylretinamide
  • UNII-187EJ7QEXL
  • DTXSID2032005
  • N-(4-Hydroxyphenyl)all-Trans Retinamide
  • 4-(hydroxyphenyl)retinamide
  • MFCD00792674
  • AC1NRB1E
  • C26H33NO2
  • FENRETINIDE [MI]
  • Fenretinide (4-HPR)?
  • RefChem:388969
  • Spectrum5_001939
  • CCRIS 3260
  • CHEMBL7301
  • FENRETINIDE [INN]
  • Retinoic acid p-hydroxyphenylamide
  • AKJHMTWEGVYYSE-FXILSDISSA-N
  • Fenretinide (USAN/INN)
  • FENRETINIDE [USAN]
  • D08JAC
  • LXS/4-HPR
  • FENRETINIDE [VANDF]
  • AC1Q1QV3
  • MLS002701698
  • 15-[(4-hydroxyphenyl)amino]retinal
  • MCNR1967
  • 4 HPR
  • FENRETINIDE [MART.]
  • HPR-4
  • Fenretinide, 13 cis Isomer
  • Fenretinide, 13-cis-Isomer
  • Lopac0_000625
  • N-(4-hydroxyphenyl)-retinamide
  • SCHEMBL11703
  • BSPBio_001419
  • DTXCID0012005
  • FENRETINIDE [WHO-DD]
  • CHEBI:42588
  • MLS001055399
  • MLS006010811
  • NSC-760419
  • SYT-101
  • 15-(4-Hydroxyanilino)retinal
  • all-trans-n-(4-hydroxyphenyl)retinamide
  • BML2-E08
  • MCN R 1967
  • orb1307289
  • SCHEMBL4380242
  • N-(4-Hydroxyphenyl)-trans-Retinamide
  • CHEBI:92493
  • AMY9087
  • AOB6402
  • BRN 5769490
  • Retinamide,N-(4-hydroxyphenyl)-
  • 15-(4-Hydroxyanilino)retinal #
  • NSC374551
  • ST-602
  • Fenretinide (oral, AMD), Sytera
  • GLXC-05374
  • HMS1361G21
  • HMS1791G21
  • HMS1989G21
  • HMS2089B17
  • HMS3261N12
  • HMS3402G21
  • HMS3412M06
  • HMS3676M06
  • HMS5084F17
  • Pharmakon1600-01505602
  • all-trans-N-4'-hydroxyretinanilide
  • NSC-374551
  • 4-(all-trans-retino-yl)aminophenol
  • 4-HPR;(4-Hydroxyphenyl)retinamide
  • BCP06908
  • EX-A4102
  • ZINC3871023
  • Tox21_111007
  • Tox21_200989
  • Tox21_500625
  • 15-((4-hydroxyphenyl)amino)retinal
  • 3670AH
  • BDBM50092055
  • C26-H33-N-O2
  • HSCI1_000112
  • LS-282
  • NCGC00090752-03
  • NSC760419
  • RT-101
  • s5233
  • CALIX[4!-BIS-CROWN-6,95
  • AKOS024456572
  • N-(4-Hydroxyphenyl)-all-trans Retinamide
  • Tox21_111007_1
  • AN-7467
  • CCG-204713
  • CID5288209
  • CS-0789
  • DB05076
  • FF23268
  • LP00625
  • N-(4-hydroxyphenyl)retinamide, 4-HPR
  • NSC 760419
  • SDCCGSBI-0050606.P002
  • CID:5288209
  • IDI1_033889
  • Retinoic acid p-hydroxyanilide, >=95%
  • NCGC00090752-01
  • NCGC00090752-02
  • NCGC00090752-04
  • NCGC00090752-05
  • NCGC00090752-06
  • NCGC00090752-07
  • NCGC00090752-09
  • NCGC00090752-10
  • NCGC00090752-11
  • NCGC00090752-12
  • NCGC00090752-20
  • NCGC00258542-01
  • NCGC00261310-01
  • AS-59667
  • BP-13369
  • HY-15373
  • J23.263G
  • SC-76490
  • SID:53786871
  • SMR000677938
  • SMR001456303
  • SY055220
  • Fenretinide (iv), Children's Hospital LA
  • (2E,4E,6E,8E)-N-(4-hydroxyphenyl)-3,7-dimethyl-9-(2,6,6-trimethylcyclohex-1-en-1-yl)nona-2,4,6,8-tetraenamide
  • AB0109574
  • CAS-65646-68-6
  • EU-0100625
  • FT-0630754
  • H1464
  • NS00069470
  • Fenretinide (soft gel capsule, AMD), Sirion
  • J2.845.877K
  • A12163
  • D04162
  • H 7779
  • W-5119
  • 33819-EP2275420A1
  • 33819-EP2295055A2
  • 33819-EP2295406A1
  • 33819-EP2295416A2
  • 33819-EP2295426A1
  • 33819-EP2295427A1
  • 33819-EP2298748A2
  • 33819-EP2298764A1
  • 33819-EP2298765A1
  • 33819-EP2305642A2
  • 33819-EP2311453A1
  • 33819-EP2311808A1
  • 33819-EP2311829A1
  • AB00172992-07
  • 646F686
  • A835178
  • D017313
  • Fenretinide (Ewing's sarcoma), Cancer Research UK
  • SR-01000075917
  • Q5443576
  • SR-01000075917-1
  • SR-01000075917-4
  • BRD-K89085489-001-19-0
  • BRD-K89085489-001-22-4
  • BRD-K89085489-001-23-2
  • Fenretinide (ILE formulation), Children's Hospital LA
  • Fenretinide (intravenous, cancer), SciTech Development
  • N-(4-HYDROXYPHENYL)-ALL-TRANS-VITAMIN A AMIDE
  • (2E,4E,6E,8E)-N-(4-hydroxyphenyl)-3,7-dimethyl-9-(2,6,6-trimethylcyclohexen-1-yl)nona-2,4,6,8-tetraenamide
  • HPR
  • B0084-074597
  • Fenretinide (soft gel capsule, AMD), ReVision Therapeutics
  • (2Z,4E,6E,8E)-N-(4-hydroxyphenyl)-3,7-dimethyl-9-(2,6,6-trimethyl-1-cyclohexenyl)nona-2,4,6,8-tetraenamide
  • 4-(HYDROXYPHENYL)-RETINAMIDE (SEE RETINOID PROJECTS 1 AND 2.)
  • Fenretinide (oral powder/Lym-X-Sorb, neuroblastoma), BioMolecular Products
  • Fenretinide (topical, actinic keratosis and cancer), SciTech Development
  • N-(4-hydroxyphenyl)-3,7-dimethyl-9-(2,6,6-trimethylcyclohex-1-en-1-yl)nona-2,4,6,8-tetraenamide
  • RETINOID PROJECT 6 (4-HPR) (SEE RETINOID PROJECTS 1,2,3,4,5)
  • Fenretinide (intralipid emulsion formulation), Children's Hospital of Los Angeles
  • RETINOID PROJECT 2 (4-(HYDROXYPHENYL)RETINAMIDE) (SEE RETINOID PROJECT 1,3,4, 5,6)
  • RETINOID PROJECT 4 (4-HYDROXYPHENYL)RETINAMIDE (SEERETINOID PROJECT 1, 2, AND 3)
  • RETINOID PROJECT 5 (4-HYDROXYPHENYL)RETINAMIDE (SEERETINOID PROJECT 1, 2, 3, 4)
  • (2E,4E,6E,8E)-3,7-Dimethyl-9-(2,6,6-trimethyl-cyclohex-1-enyl)-nona-2,4,6,8-tetraenoic acid (4-hydroxy-phenyl)-amide
  • (2E,4E,6E,8E)-N-(4-Hydroxyphenyl)-3,7-dimethyl-9-(2,6,6-trimethyl-1-cyclohexen-1-yl)-2,4,6,8-nonatetraenamide
  • (2E,4E,6E,8E)-N-(4-Hydroxyphenyl)-3,7-dimethyl-9-(2,6,6-trimethyl-1-cyclohexenyl)nona-2,4,6,8-tetraenamide
  • (2E,4E,6E,8E)-N-(4-hydroxyphenyl)-3,7-dimethyl-9-(2,6,6-trimethylcyclohex-1-enyl)nona-2,4,6,8-tetraenamide
  • 2,6,8-Nonatetraenamide, N-(4-hydroxyphenyl)-3,7-dimethyl-9-(2,6,6-trimethyl-1-cyclohexen-1-yl-, (all-E)-
  • 3,7-Dimethyl-9-(2,6,6-trimethyl-cyclohex-1-enyl)-nona-2,4,6,8-tetraenoic acid (4-hydroxy-phenyl)-amide
  • 75686-07-6
  • FEN
  • Fenretinide (intravenous emulsion, lymphoma/solid tumors/pediatric neuroblastomas/pediatric leukemia), CerRx
  • Fenretinide (pulmonary Pseudomonas aeruginosa infections in cystic fibrosis), McGill University
  • N-(4-Hydroxyphenyl)-3,7-dimethyl-9-(2,6,6-trimethyl-1-cyclohexenyl)-2,4,6,8-nonatetraeneamide
  • N-(4-hydroxyphenyl)-3,7-dimethyl-9-(2,6,6-trimethyl-1-cyclohexenyl)nona-2,4,6,8-tetraenamide